BusinessElite Pharmaceuticals Announces Changes to their Board of DirectorsBy Nasdaq OMXApr 12, 2016, 12:00 PM UTC
BusinessElite Announces U.S. FDA Priority Review Designation for SequestOx™ NDABy Nasdaq OMXMar 17, 2016, 11:00 AM UTC
BusinessElite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016By Nasdaq OMXFeb 9, 2016, 9:31 PM UTC
BusinessElite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016By Nasdaq OMXFeb 5, 2016, 5:43 PM UTC
